239 related articles for article (PubMed ID: 24853655)
21. Membrane interactions of antimicrobial peptides from Australian frogs.
Fernandez DI; Gehman JD; Separovic F
Biochim Biophys Acta; 2009 Aug; 1788(8):1630-8. PubMed ID: 19013126
[TBL] [Abstract][Full Text] [Related]
22. Utilizing zeta potential measurements to study the effective charge, membrane partitioning, and membrane permeation of the lipopeptide surfactin.
Fan HY; Nazari M; Raval G; Khan Z; Patel H; Heerklotz H
Biochim Biophys Acta; 2014 Sep; 1838(9):2306-12. PubMed ID: 24631665
[TBL] [Abstract][Full Text] [Related]
23. Gram-positive bacterial cell envelopes: The impact on the activity of antimicrobial peptides.
Malanovic N; Lohner K
Biochim Biophys Acta; 2016 May; 1858(5):936-46. PubMed ID: 26577273
[TBL] [Abstract][Full Text] [Related]
24. Interactions of Antimicrobial Peptides with Bacterial Membranes and Membrane Components.
Malmsten M
Curr Top Med Chem; 2016; 16(1):16-24. PubMed ID: 26139113
[TBL] [Abstract][Full Text] [Related]
25. Role of Lipid Composition, Physicochemical Interactions, and Membrane Mechanics in the Molecular Actions of Microbial Cyclic Lipopeptides.
Balleza D; Alessandrini A; Beltrán García MJ
J Membr Biol; 2019 Jun; 252(2-3):131-157. PubMed ID: 31098678
[TBL] [Abstract][Full Text] [Related]
26. Mechanical properties that influence antimicrobial peptide activity in lipid membranes.
Marín-Medina N; Ramírez DA; Trier S; Leidy C
Appl Microbiol Biotechnol; 2016 Dec; 100(24):10251-10263. PubMed ID: 27837316
[TBL] [Abstract][Full Text] [Related]
27. Molecular mechanisms of membrane perturbation by antimicrobial peptides and the use of biophysical studies in the design of novel peptide antibiotics.
Lohner K; Blondelle SE
Comb Chem High Throughput Screen; 2005 May; 8(3):241-56. PubMed ID: 15892626
[TBL] [Abstract][Full Text] [Related]
28. Differential scanning calorimetry and X-ray diffraction studies of the specificity of the interaction of antimicrobial peptides with membrane-mimetic systems.
Lohner K; Prenner EJ
Biochim Biophys Acta; 1999 Dec; 1462(1-2):141-56. PubMed ID: 10590306
[TBL] [Abstract][Full Text] [Related]
29. Coupling molecular dynamics simulations with experiments for the rational design of indolicidin-analogous antimicrobial peptides.
Tsai CW; Hsu NY; Wang CH; Lu CY; Chang Y; Tsai HH; Ruaan RC
J Mol Biol; 2009 Sep; 392(3):837-54. PubMed ID: 19576903
[TBL] [Abstract][Full Text] [Related]
30. The effect of membrane curvature on the conformation of antimicrobial peptides: implications for binding and the mechanism of action.
Chen R; Mark AE
Eur Biophys J; 2011 Apr; 40(4):545-53. PubMed ID: 21267557
[TBL] [Abstract][Full Text] [Related]
31. Interaction studies of novel cell selective antimicrobial peptides with model membranes and E. coli ATCC 11775.
Joshi S; Bisht GS; Rawat DS; Kumar A; Kumar R; Maiti S; Pasha S
Biochim Biophys Acta; 2010 Oct; 1798(10):1864-75. PubMed ID: 20599694
[TBL] [Abstract][Full Text] [Related]
32. Limiting an antimicrobial peptide to the lipid-water interface enhances its bacterial membrane selectivity: a case study of MSI-367.
Thennarasu S; Huang R; Lee DK; Yang P; Maloy L; Chen Z; Ramamoorthy A
Biochemistry; 2010 Dec; 49(50):10595-605. PubMed ID: 21062093
[TBL] [Abstract][Full Text] [Related]
33. Concentration-dependent realignment of the antimicrobial peptide PGLa in lipid membranes observed by solid-state 19F-NMR.
Glaser RW; Sachse C; Dürr UH; Wadhwani P; Afonin S; Strandberg E; Ulrich AS
Biophys J; 2005 May; 88(5):3392-7. PubMed ID: 15695635
[TBL] [Abstract][Full Text] [Related]
34. Insight into the antimicrobial mechanism of action of β
Koivuniemi A; Fallarero A; Bunker A
Biochim Biophys Acta Biomembr; 2019 Nov; 1861(11):183028. PubMed ID: 31376362
[TBL] [Abstract][Full Text] [Related]
35. Membrane insertion and bilayer perturbation by antimicrobial peptide CM15.
Pistolesi S; Pogni R; Feix JB
Biophys J; 2007 Sep; 93(5):1651-60. PubMed ID: 17496013
[TBL] [Abstract][Full Text] [Related]
36. Absorption and folding of melittin onto lipid bilayer membranes via unbiased atomic detail microsecond molecular dynamics simulation.
Chen CH; Wiedman G; Khan A; Ulmschneider MB
Biochim Biophys Acta; 2014 Sep; 1838(9):2243-9. PubMed ID: 24769159
[TBL] [Abstract][Full Text] [Related]
37. Describing the mechanism of antimicrobial peptide action with the interfacial activity model.
Wimley WC
ACS Chem Biol; 2010 Oct; 5(10):905-17. PubMed ID: 20698568
[TBL] [Abstract][Full Text] [Related]
38. The efficacy of trivalent cyclic hexapeptides to induce lipid clustering in PG/PE membranes correlates with their antimicrobial activity.
Finger S; Kerth A; Dathe M; Blume A
Biochim Biophys Acta; 2015 Nov; 1848(11 Pt A):2998-3006. PubMed ID: 26367060
[TBL] [Abstract][Full Text] [Related]
39. Influence of antimicrobial peptides on the formation of nonlamellar lipid mesophases.
Hickel A; Danner-Pongratz S; Amenitsch H; Degovics G; Rappolt M; Lohner K; Pabst G
Biochim Biophys Acta; 2008 Oct; 1778(10):2325-33. PubMed ID: 18582435
[TBL] [Abstract][Full Text] [Related]
40. Beyond electrostatics: Antimicrobial peptide selectivity and the influence of cholesterol-mediated fluidity and lipid chain length on protegrin-1 activity.
Henderson JM; Iyengar NS; Lam KLH; Maldonado E; Suwatthee T; Roy I; Waring AJ; Lee KYC
Biochim Biophys Acta Biomembr; 2019 Oct; 1861(10):182977. PubMed ID: 31077677
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
